Suchergebnisse - "Nguyen, Bach"

PubPharm (6)

1

Efficacy of raltegravir versus efavirenz when combined with tenofovir/emtricitabine in treatment-naïve HIV-1-infected patients : week-192 overall and subgroup analyses from STARTMRK

enthalten in: HIV clinical trials | 2012

von DeJesus, E. | Rockstroh, J. | Lennox, J. | +80

ErratumIn: HIV Clin Trials. 2012 Sep-Oct;13(5):preceding 233

2

A nucleoside- and ritonavir-sparing regimen containing atazanavir plus raltegravir in antiretroviral treatment-naïve HIV-infected patients : SPARTAN study results

enthalten in: HIV clinical trials | 2012

von Kozal, M. | Lupo, S. | DeJesus, E. | +17

3

A Nucleoside- and Ritonavir-Sparing Regimen Containing Atazanavir Plus Raltegravir in Antiretroviral Treatment-Naïve HIV-Infected Patients: SPARTAN Study Results

enthalten in: HIV clinical trials | 2012

von Kozal, M. | Lupo, S. | DeJesus, E. | +16

4

Efficacy of Raltegravir Versus Efavirenz When Combined With Tenofovir/ Emtricitabine in Treatment-Naïve HIV-1–Infected Patients: Week-192 Overall and Subgroup Analyses From STARTMRK

enthalten in: HIV clinical trials | 2012

von DeJesus, E. | Rockstroh, J. | Lennox, J. | +12

5

Association of efavirenz hypersusceptibility with virologic response in ACTG 368, a randomized trial of abacavir (ABC) in combination with efavirenz (EFV) and indinavir (IDV) in HIV-infected subjects with prior nucleoside analog experience

enthalten in: HIV clinical trials | 2008

von Demeter, L. | DeGruttola, V. | Lustgarten, S. | +9

6

Association of Efavirenz Hypersusceptibility with Virologic Response in ACTG 368, a Randomized Trial of Abacavir (ABC) in Combination with Efavirenz (EFV) and Indinavir (IDV) in HIV-Infected Subjects with Prior Nucleoside Analog Experience

enthalten in: HIV clinical trials | 2008

von Demeter, L. | Degruttola, V. | Lustgarten, S. | +9

1
[1]